Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety, tolerability, and immunogenicity of Zoster Vaccine Live (ZOSTAVAX) in healthy adults in India has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Shingles

Drugs mentioned

• Zoster Vaccine Live (ZOSTAVAX) (zoster vaccine live)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster, Shingles | Phase 3 | Status: COMPLETED | Results posted: 2013-12-30